ASCO: Bristol Myers delves into Opdualag’s LAG-3 melanoma win in key populations
ASCO: Bristol Myers delves into Opdualag’s LAG-3 melanoma win in [...]
ASCO: Bristol Myers delves into Opdualag’s LAG-3 melanoma win in [...]
Sanofi, Regeneron’s Libtayo scores UK watchdog’s approval in common form [...]
Eli Lilly plots $2.1B manufacturing expansion at America’s crossroads, with [...]
Teva, AbbVie’s Allergan hand over $161M to settle opioid lawsuit [...]
Kadmon consultant charged with insider trading ahead of biotech’s $1.9B [...]
US to provide Bavarian Nordic’s vaccine Jynneos to some at [...]
Moderna CEO Bancel uses inaugural stock option to give $355M [...]
In bankruptcy case, U.S. wants court to block J&J’s use [...]
Seagen’s potential breast cancer blockbuster Tukysa shows promise in colorectal [...]
GSK dodges UK strike with improved pay offer for staffers [...]